Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 23;13:1756284820932483. doi: 10.1177/1756284820932483

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 8. — Comparisons and ranking curves of efficacy in the subgroups.

Each cell of the block contains the pooled odds ratios and 95% credibility intervals for OS and PFS. Significant results are in bold. (a) AFP >400 subgroup, (b) MVI subgroup, (c) EHS subgroup, (d) ECOG PS1 subgroup, (e) ranking curves indicate the probability of the benefit of OS and PFS in AFP >400 subgroup. AFP, alpha-fetoprotein; ECOG PS, Eastern Cooperative Oncology Group performance status; EHS, extrahepatic spread; MVI, macrovascular invasion; PFS, progression-free survival; OS, overall survival